News

Explore the booming Artificial Intelligence in Pathology market. Asia-Pacific leads the market, while North America is the ...
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting ...
Wedbush tech analyst and longtime AI bull Dan Ives is lending his name to a new exchange-traded fund built around his picks ...
Explore the Dan Ives Wedbush AI Revolution ETF (IVES), targeting 30 top AI-driven companies across diverse sectors.
AI Steals the Show on Wall Street Early on, like with any new and ground-breaking technology, there were AI skeptics, but by now, most of Wall Street has caught on to just how big the AI revolution ...
While Nvidia has taken the AI market by storm, there's a chance that Amazon's (AMZN 0.81%) AWS division will be the true ...
Tempus AI extended its winning streak to a third consecutive day on Monday, jumping 15.02 percent to close at $63.47 apiece ...
Shares of Tempus AI (NASDAQ: TEM) soared on Monday. The company's stock jumped 15% as of market close. The spike comes as the ...
Tempus AI Inc. (NASDAQ:TEM) announced the introduction of xM for treatment response monitoring/TRM. This new liquid biopsy ...
Shares of Tempus AI Inc (NASDAQ:TEM) surged 15% on Monday, recovering some of last week’s sharp losses after a short-seller report from Spruce Point Capital triggered a 13% weekly drop. The rebound ...
Tempus AI Inc. (NASDAQ:TEM) announced the expansion of its GenAI clinical assistant, called Tempus One, with direct ...
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Tempus AI, Inc. (NASDAQ: TEM) resulting from allegations ...